Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (3 ops.)
Latest filing published 14 Sept 2026 for Vera Therapeutics, Inc., €17k. Read the official filing
Filing timeline
BuySaleJoseph R. Young
Insider track record
Disclosed buys
2
Disclosed sells
3
T+90 hit rate
100%
T+90 mean return
+1.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Joseph R. Young: trading record in brief
All filings by Joseph R. Young on record concern Vera Therapeutics, Inc. Over a trading history stretching from 6 February 2022 to 11 September 2026, the count stands at 13 filings.
On the open market, the record shows 2 purchases worth €72k and 3 sales worth €700k. Netting one side against the other leaves €628k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 4 share grants and 4 option exercises. 2026 to date brings no purchases and 1 sale.
The latest filing, published on 14 September 2026, reports an option exercise of €17k in Vera Therapeutics, Inc. The latest purchase dates back some time: it was published 1,339 days ago, on 17 February 2023. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Joseph R. Young
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
5,000 shares@ US$3.93960.0008% mcap2.0% of flowClass A Common StockSEC:0001861684-26-000006:0
10,000 shares@ US$3.93968.9% of flowClass A Common StockSEC:0001861684-26-000005:0
3,117 shares@ US$41.983912.7% of flowClass A Common StockSEC:0001861684-26-000004:0
10,000 shares0Class A Common StockSEC:0001861684-26-000002:0
15,000 shares@ US$29.058349.5% of flowClass A Common StockSEC:0001193125-25-280792:0
10,740 shares0Class A Common StockSEC:0001415889-25-004851:0
8,221 shares@ US$3.93968.5% of flowClass A Common StockSEC:0001415889-24-013504:0
5,714 shares@ US$40.0060.6% of flowClass A Common StockSEC:0001415889-24-010753:0
21,875 shares0Class A Common StockSEC:0001415889-24-001518:0
10,000 shares@ US$3.939610.3% of flowClass A Common StockSEC:0001209191-23-041521:0
5,714 shares@ US$7.0010.6% of flowClass A Common StockSEC:0001209191-23-010595:0
Canonical exit: 7 May 2023 (T+90)
5,714 shares@ US$7.0010.0% of flowClass A Common StockSEC:0001209191-23-007770:0
Canonical exit: 7 May 2022 (T+90)
15,000 shares0Class A Common StockSEC:0001209191-22-047167:0
13 of 13 declarations
